References
- 1. Amir RE, Van dV, I, Wan M, Tran CQ, Francke U, Zoghbi HY (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.
- 2. Hagberg B, Aicardi J, Dias K, Ramos O (1983). A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 14: 471-479.
- 3. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, et al. (2010). Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68: 944-950.
- 4. Zappella M (1992). The Rett girls with preserved speech. Brain Dev 14: 98-101.
- 5. Rolando S (1985). Rett syndrome: report of eight cases. Brain Dev 7: 290-296.
- 6. Hanefeld F (1985). The clinical pattern of the Rett syndrome. Brain Dev 7: 320-325.
- 7. Shahbazian MD, Zoghbi HY (2002). Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet 71: 1259-1272.
- 8. De BC, Zappella M, Hayek G, Meloni I, Vitelli F, Bruttini M, et al. (2000). Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet 8: 325-330.
- 9. Zappella M, Meloni I, Longo I, Canitano R, Hayek G, Rosaia L, et al. (2003). Study of MECP2 gene in Rett syndrome variants and autistic girls. Am J Med Genet B Neuropsychiatr Genet 119B: 102-107.
- 10. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, et al. (1992). Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69: 905-914.
- 11. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, et al. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389.
- 12. Nan X, Tate P, Li E, Bird A (1996). DNA methylation specifies chromosomal localization of MeCP2. Mol Cell Biol 16: 414-421.
- 13. Chandler SP, Guschin D, Landsberger N, Wolffe AP (1999). The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry 38: 7008-7018.
- 14. Ballestar E, Yusufzai TM, Wolffe AP (2000). Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry 39: 7100-7106.
- 15. Yusufzai TM, Wolffe AP (2000). Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28: 4172-4179.
- 16. NCBI. http://www.ncbi.nlm.nih.gov/gene/4204.20137-15-2013. Ref Type: Electronic Citation
- 17. HUGO. http://www.genenames.org/data/hgnc_data.php?hgnc_id=6990 . 2011. 7-15-2013. Ref Type: Electronic Citation
- 18. USCS genome browser. http://genome.ucsc.edu/cgibin/hgBlat?command=start . 2009. 7-15-2013. Ref Type: Electronic Citation
- 19. USCSdbSNP(137). http://genome.ucsc.edu/cgibin/hgTrackUi?hgsid=342271035&c=chrX&g=snp137- Common . 2012. Ref Type: Electronic Citation
- 20. Ohki I, Shimotake N, Fujita N, Nakao M, Shirakawa M (1999). Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1. EMBO J 18: 6653-6661.
- 21. Goffin D, Allen M, Zhang L, Amorim M, Wang IT, Reyes AR, et al. (2012). Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat Neurosci 15: 274-283.
- 22. Obata K, Matsuishi T, Yamashita Y, Fukuda T, Kuwajima K, Horiuchi I, et al. (2000). Mutation analysis of the methyl-CpG binding protein 2 gene (MECP2) in patients with Rett syndrome. J Med Genet 37: 608-610.
- 23. Baker SA, Chen L, Wilkins AD, Yu P, Lichtarge O, Zoghbi HY (2013). An AT-hook domain in MeCP2 determines the clinical course of Rett syndrome and related disorders. Cell 152: 984-996.
- 24. Klose RJ, Sarraf SA, Schmiedeberg L, McDermott SM, Stancheva I, Bird AP (2005). DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 19: 667-678.
- 25. Nan X, Campoy FJ, Bird A (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481.
- 26. Cheadle JP, Gill H, Fleming N, Maynard J, Kerr A, Leonard H, et al. (2000). Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet 9: 1119-1129.
- 27. Kammoun F, de RN, Boespflug-Tanguy O, Vallee L, Seng R, Tardieu M, et al. (2004). Screening of MECP2 coding sequence in patients with phenotypes of decreasing likelihood for Rett syndrome: a cohort of 171 cases. J Med Genet 41: e85.
- 28. Ravn K, Nielsen JB, Skjeldal OH, Kerr A, Hulten M, Schwartz M (2005). Large genomic rearrangements in MECP2. Hum Mutat 25: 324.